SCHEMBL5230665

SCHEMBL5230665

Cc1cccc(-c2nc(C(C)C)[nH]c2-c2cccc(-c3ccc(C(=O)NCCO)cc3)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.49
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GRM5 P41594 2/20 0.38
PTK2 Q05397 1/20 0.37
ATR Q13535 1/20 0.37
TLR9 Q9NR96 2/20 0.37
TLR8 Q9NR97 2/20 0.37
TLR7 Q9NYK1 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
FYN P06241 1/20 0.36
LIPC P11150 1/20 0.36
PTAFR P25105 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199910 0.85 RXRA (0.46) TGFBR1KDM4EALDH1A1GRM5
SCHEMBL5226169 0.84 TGFBR1 (0.46) TGFBR1KDM4E
SCHEMBL5224356 0.81 TGFBR1 (0.58) TGFBR1ATRTLR9TLR8TLR7
SCHEMBL5199410 0.78 POLB (0.47) TGFBR1ALDH1A1GRM5ATRTLR9
SCHEMBL5200756 0.77 TGFBR1 (0.49) TGFBR1RAB9A
SCHEMBL5199960 0.77 TGFBR1 (0.42) TGFBR1KDM4EALDH1A1GRM5TLR9
SCHEMBL5199177 0.77 TGFBR1 (0.54) TGFBR1KDM4ESMN1; SMN2
SCHEMBL5198098 0.76 TGFBR1 (0.42) TGFBR1KDM4EGRM5TLR9TLR8
SCHEMBL5197863 0.76 CA2 (0.46) TGFBR1KDM4ECA12CA1CA2
SCHEMBL5227673 0.76 TLR8 (0.50) TGFBR1KDM4EGRM5TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TGFBR1 40/4885KDM4E 806/4885ALDH1A1 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.